Association of transforming growth factor-β1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 5, 2006, Pages 1114-1119

  Koch, Werner ^a   Hoppmann, Petra ^a   Mueller, Jakob C ^b,c   Schömig, Albert ^a   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Haplotype; Myocardial infarction; SNP; TGFB1; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANGIOGRAPHY; ARTERY WALL; ARTICLE; CARDIAC PATIENT; CELL PROLIFERATION; CIGARETTE SMOKING; DNA POLYMORPHISM; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TGFB1 GENE; ANGIOCARDIOGRAPHY; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; STATISTICAL MODEL;

ADULT; AGED; COHORT STUDIES; CORONARY ANGIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33646456211     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000217747.66517.11     Document Type: Article

References (37)

1. Grainger DJ. Transforming growth factor β and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol. 2004;24:399-404.
2. Mallat Z, Tedgui A. The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives. Curr Opin Lipidol. 2002;13:523-529.
3. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor β in human disease. N Engl J Med. 2000;342:1350-1358.
4. Gamble JR, Vadas MA. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β. Science. 1988;242:97-99.
5. Gamble JR, Vadas MA. Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-β. J Immunol. 1991;146:1149-1154.
6. Smith WB, Noack L, Khew-Goodall Y, Isenmann S, Vadas MA, Gamble JR. Transforming growth factor-β1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J Immunol. 1996;157:360-368.
7. DiChiara MR, Kiely JM, Gimbrone MA Jr, Lee M-E, Perrella MA, Topper JN. Inhibition of E-selectin gene expression by transforming growth factor β in endothelial cells involves coactivator integration of Smad and nuclear factor κB-mediated signals. J Exp Med. 2000;192: 695-704.
8. Kawai-Kowase K, Sato H, Oyama Y, Kanai H, Sato M, Doi H, Kurabayashi M. Basic fibroblast growth factor antagonizes transforming growth factor-β1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation. Arterioscler Thromb Vasc Biol. 2004;24:1384-1390.
9. Vodovotz Y, Bogdan C, Paik J, Xie Q-w, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J Exp Med. 1993;178:605-613.
10. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol. 1998;16:137-161.
11. Gorelik L, Flavell RA. Transforming growth factor-β in T-cell biology. Nat Rev Immunol. 2002;2:46-53.
12. Argmann CA, Van Den Diepstraten CH, Sawyez CG, Edwards JY, Hegele RA, Wolfe BM, Huff MW. Transforming growth factor-β1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler Thromb Vasc Biol. 2001;21: 2011-2018.
13. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamaté C, Merval R, Fradelizi D, Tedgui A. Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res. 2001;89:930-934.
14. Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky VE, Daemen MJAP. Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol. 2002;22:975-982.
15. Gojova A, Brun V, Esposito B, Cottrez F, Gourdy P, Ardouin P, Tedgui A, Mallat Z, Groux H. Specific abrogation of transforming growth factor-β signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood. 2003;102:4052-4058.
16. Cambien F, Ricard S, Troesch A, Mallet C, Générénaz L, Evans A, Arveiler D, Luc G, Ruidavets J-B, Poirier O. Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure: the etude cas-témoin de l'infarctus du myocarde (ECTIM) study. Hypertension. 1996;28:881-887.
17. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-β1 gene. Transplantation. 1998;66:1014-1020.
18. Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, Crossman DC, Francis SE, Gunn J, Jeffery S, Heathcote K. Transforming growth factor-β1 gene polymorphisms and coronary artery disease. Clin Sci. 1998;95:659-667.
19. Wang XL, Sim AS, Wilcken DEL. A common polymorphism of the transforming growth factor-β1 gene and coronary artery disease. Clin Sci. 1998;95:745-746.
20. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A, Ikeda K. Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res. 1998;13:1569-1576.
21. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet. 1999;8:93-97.
22. Yokota M, Ichihara S, Lin T-L, Nakashima N, Yamada Y. Association of a T29→C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation. 2000;101:2783-2787.
23. 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A. 2000;97:3479-3484.
24. 1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med. 2004;169:214-219.
25. Luedecking EK, DeKosky ST, Mehdi H, Ganguli M, Kamboh MI. Analysis of genetic polymorphisms in the transforming growth factor-β1 gene and the risk of Alzheimer's disease. Hum Genet. 2000;106:565-569.
26. Dubois CM, Laprise M-H, Blanchette F, Gentry LE, Leduc R. Processing of transforming growth factor β1 precursor by human furin convertase. J Biol Chem. 1995;270:10618-10624.
27. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999;17:151-183.
28. World Health Organization Study Group. Diabetes mellitus. WHO Tech Rep Ser. 1985;727:1-104.
29. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68: 978-989.
30. Schuit SCE, Oei H-HS, Witteman JCM, Geurts van Kessel CH, van Meurs JBJ, Nijhuis RL, van Leeuwen JPTM, de Jong EH, Zillikens MC, Hofman A, Pols HAP, Uitterlinden AG. Estrogen receptor a gene polymorphisms and risk of myocardial infarction. JAMA. 2004;291: 2969-2977.
31. Hubacek JA, Lacha J. Alternative method for diagnosis of two polymorphisms in the human transforming growth factor-β1 by PCR-mediated double site-directed mutagenesis. Clin Chim Acta. 2000;295: 187-191.
32. Bučkova D, Izakovičová Hollá L, Beneš P, Znojil V, Vácha J. TGF-β1 gene polymorphisms. Allergy. 2001;56:1236-1237.
33. 1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168:431-435.
34. Hegele RA. SNP judgments and freedom of association. Arterioscler Thromb Vasc Biol. 2002;22:1058-1061.
35. Marchini J, Cardon LR, Phillips MS, Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet. 2004;36:512-517.
36. Parra HJ, Arveiler D, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D, Schaffer P, Douste-Blazy PH, Luc G, Richard JL, Ducimetière P, Fruchart JC, Cambien F. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: the ECTIM study. Arterioscler Thromb. 1992;12:701-707.
37. Sugiura Y, Niimi T, Sato S, Yoshinouchi T, Banno S, Naniwa T, Maeda H, Shimizu S, Ueda R. Transforming growth factor β1 gene polymorphism in rheumatoid arthritis. Ann Rheum Dis. 2002;61:826-828.